Results 91 to 100 of about 469 (114)
The Efficacy and Safety of Levosimendan in Patients with Advanced Heart Failure: An Updated Meta-Analysis of Randomized Controlled Trials. [PDF]
Elsaeidy AS +10 more
europepmc +1 more source
Levosimendan and Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials. [PDF]
Wan H, Feng J, Ji P, Chen W, Zhang J.
europepmc +1 more source
Effect of Luhong formula on the cardiac rehabilitation of patients with chronic heart failure. [PDF]
Xu JJ +5 more
europepmc +1 more source
Linee guida ESC per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico 2008 = Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 [PDF]
Atar, D. +14 more
core
The favourable alliance between CardioMEMS and levosimendan in patients with advanced heart failure. [PDF]
Visco V +11 more
europepmc +1 more source
AbstractHerein, the enantiomeric separation of simendan by high‐performance liquid chromatography with ultraviolet detection using polysaccharide‐based chiral stationary phases in polar organic mode is described. Three chiral columns (Chiralpak AD‐H, Chiralcel OD‐H, and Chiralpak AS) were screened using pure methanol and acetonitrile without additives ...
Lingping Cheng +3 more
openaire +3 more sources
rac-Simendan, (+/-)-(R,S)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-phenyl ] hydrazono]propanedinitrile, and the levorotatory enantiomer levosimendan, are drug candidates intended for the treatment of congestive heart failure. An enantiospecific high-performance liquid chromatographic (HPLC) method suitable for determination of the ratio of
T, Wikberg, T, Korkolainen, M, Karlsson
openaire +3 more sources
Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteers
To assess pharmacokinetics and correlation of pharmacokinetics and pharmacodynamics of simendan, a new calcium-sensitizing compound aimed at the treatment of congestive heart failure, in healthy volunteers.Simendan was administered to eight healthy subjects in seven different doses, and its concentrations in plasma and proportions of enantiomers ...
J, Lilleberg +4 more
openaire +3 more sources

